Paul K. Audhya - 11 Feb 2024 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Benjamin L. Palleiko, Attorney-in-Fact
Issuer symbol: KALV
Transactions as of: 11 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 13 Feb 2024, 09:06:07 UTC
Previous filing: 21 Nov 2023
Next filing: 21 Feb 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KALV	Performance Stock Units	Award	$0	+48,333		$0.000000	48,333	11 Feb 2024	Common Stock	48,333		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each PSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2	Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on January 10, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of Performance Metrics. 1/4th of the total number of shares subject to the PSU shall vest on each quarterly anniversary of the Vesting Commencement Date of February 17, 2024, upon Performance Metrics achieved, subject to continued service through each vesting date.

Content

Each PSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on January 10, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of Performance Metrics. 1/4th of the total number of shares subject to the PSU shall vest on each quarterly anniversary of the Vesting Commencement Date of February 17, 2024, upon Performance Metrics achieved, subject to continued service through each vesting date.